| Date | Name | Shares | Transaction | Value |
|
Apr 4, 2025
| David W. Nelms Director |
30,097
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Apr 4, 2025
| Joseph R. Swedish Director |
17,497
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 21, 2025
| Katherine Elizabeth Sanderson See Remarks |
21,766
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $167 per share |
3,634,922.00
|
|
Mar 14, 2025
| Marc E. Jones Director |
2,826
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 14, 2025
| Christine A. Leahy See Remarks; Director |
145,924
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 14, 2025
| Virginia C. Addicott Director |
16,607
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 14, 2025
| Elizabeth H. Connelly See Remarks |
22,498
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.05 per share |
3,735,792.90
|
|
Mar 14, 2025
| Elizabeth H. Connelly See Remarks |
22,662
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 14, 2025
| Frederick J. Kulevich See Remarks |
36,077
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.05 per share |
5,990,585.85
|
|
Mar 14, 2025
| Frederick J. Kulevich See Remarks |
36,302
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 14, 2025
| Anthony R. Foxx Director |
4,994
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 14, 2025
| Kelly Jean Grier Director |
2,418
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 14, 2025
| Christine A. Leahy See Remarks; Director |
144,931
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.05 per share |
24,065,792.55
|
|
Mar 14, 2025
| Lynda M. Clarizio Director |
14,442
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 14, 2025
| Sona Chawla See Remarks |
35,439
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.05 per share |
5,884,645.95
|
|
Mar 14, 2025
| Sona Chawla See Remarks |
35,937
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 14, 2025
| Sanjay Mehrotra Director |
4,739
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 14, 2025
| Donna F. Zarcone Director |
21,110
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 14, 2025
| Albert Joseph Miralles See Remarks |
32,999
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.05 per share |
5,479,483.95
|
|
Mar 14, 2025
| Albert Joseph Miralles See Remarks |
33,364
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|